US$ 26.63
glp-1 agonist indications Drugs: Where We Are and Where We're Going — Summit Re GLP-1 receptor agonists and next-generation
Description
doi: 10.1016/S0140-6736(64)90011-X [DOI] [PubMed] [Google Scholar] 6

They fight inflammation, protect cells from damage, provide benefits to blood vessels, and reduce protein excretion in urine [27]
46 Drug-Drug Interactions: Saxagliptin is a strong CYP3A4 inhibitor, so its labeling recommends limiting saxagliptin to 2.5 mg daily in patients taking other strong CYP3A4 inhibitors, such as ketoconazole, based on the risk of increased saxagliptin levels
Since in all of the above studies the terminologies NAFLD/NASH were applied, these definitions will be used in this review

However, individual circumstances vary, so discuss combinations with your prescriber

JAAPA 33:318
